Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Biochemical and Biophysical Research Communications|April 22, 2009
Modulation effect of filamentous phage on alpha-synuclein aggregationHemi Dimant, Noa Sharon, Beka SolomonNeuro-Degenerative Diseases|March 13, 2010
Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cellsHemi Dimant, Beka SolomonJournal of Immunotherapy (Hagerstown, Md. : 1997)|February 9, 2010
TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variantsSara Orgad, Hemi Dimant, Eyal Dor-On, et al.Journal of Molecular Neuroscience : MN|September 23, 2003
Immunological approach for the treatment of Alzheimer's diseaseBeka SolomonMini Reviews in Medicinal Chemistry|October 9, 2002
Towards Alzheimer's disease vaccinationBeka SolomonCurrent Opinion in Investigational Drugs (London, England : 2000)|July 31, 2007
Antibody-mediated immunotherapy for Alzheimer's diseaseBeka SolomonDrug News & Perspectives|April 5, 2003
Protective Molecules in Alzheimer's Disease: Therapeutic AntibodiesBeka SolomonCurrent Medicinal Chemistry|October 9, 2002
Anti-aggregating antibodies, a new approach towards treatment of conformational diseasesBeka SolomonRejuvenation Research|March 18, 2008
Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's diseaseBeka SolomonExpert Opinion on Investigational Drugs|May 16, 2007
Clinical immunologic approaches for the treatment of Alzheimer's diseaseBeka SolomonPageof 6